What is Biloba?
Biloba operates as a telehealth company and platform provider, with a distinct specialization in pediatric care. Based in Paris, France, the company was founded in 2018 with the mission to bridge gaps in healthcare accessibility for children. Its platform offers a comprehensive solution for remote medical consultations and services tailored to the unique needs of young patients, positioning it as a key player in the rapidly expanding digital health market.
How much funding has Biloba raised?
Biloba has raised a total of $1.7M across 1 funding round:
Angel/Seed
$1.7M
Angel/Seed (2021): $1.7M with participation from Acequia Capital, Inventures, ID4, Calm/Storm Ventures, and Aglaé Ventures
Key Investors in Biloba
Acequia Capital
Acequia Capital is a venture capital firm that invests in early-stage technology companies, indicating a focus on innovative startups with high growth potential.
Inventures
Inventures is a venture capital firm, likely focused on supporting companies with innovative business models and strong market opportunities.
Calm/Storm Ventures
Calm/Storm Ventures is a boutique venture capital firm specializing in early-stage HealthTech companies, with a commitment to creating both impact and financial returns.
What's next for Biloba?
The recent major strategic investment in Biloba signals a pivotal moment for the company's expansion and service enhancement. This capital infusion is expected to fuel further development of its pediatric telehealth platform, potentially broadening its geographical reach and deepening its service offerings. Strategic partnerships and technological advancements are likely to be key priorities as Biloba aims to solidify its position and scale its impact within the global healthcare landscape.
See full Biloba company page
